fullerene c60 has been researched along with Breast Cancer in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 15 (83.33) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Katare, OP; Kumar, M; Kumar, R; Misra, C; Raza, K; Sharma, G; Singh, B | 1 |
| Avgoustakis, K; Bantzi, M; Barbouri, D; Gialeli, C; Giannis, A; Karamanos, NK; Magoulas, GE; Messari, D; Papaioannou, D; Voulgari, E | 1 |
| Chen, Z; Hou, L; Shi, J; Wang, B; Wang, L; Xu, L; Zhang, Z | 1 |
| Agarwal, P; He, X; Lu, X; Wang, H; Yu, J; Zhao, S | 1 |
| Angerer, TB; Fletcher, JS; Landberg, G; Magnusson, Y | 1 |
| Baltić, VV; Bogdanović, G; Canadanović-Brunet, J; Dordević, A; Kojić, V; Vojinović-Miloradov, M | 1 |
| Korzuch, J; Malarz, K; Musioł, R; Serda, M; Szubka, M; Zubko, M | 1 |
| Cai, R; Chen, C; Liu, Y; Miao, Q; Nie, X; Tang, J; Zhao, Y | 1 |
| Chen, C; Han, Z; Lu, ZR; Roelle, S; Schiemann, WP; Wu, X | 1 |
| Kepinska, M; Kizek, R; Milnerowicz, H | 1 |
| Bai, X; Chang, Y; Chen, K; Dong, X; Gu, W; Lei, R; Li, J; Li, S; Ma, S; Qin, Y; Xia, S; Xing, G; Zeng, L; Zhang, J | 1 |
| Li, L; Ma, R; Shi, J; Wang, H; Wang, L; Wang, Z; Yu, X; Zhang, J; Zhang, Z | 1 |
| Balogh, LP | 1 |
| Conyers, JL; Joshi, PP; Lyon, JL; Mitchell, LR; Partha, R | 1 |
| Cao, L; Haque, SA; Lacher, S; Liu, JH; Liu, Y; Lu, F; Luo, PG; Meziani, MJ; Sun, YP; Wang, H; Yang, ST | 1 |
| Grobmyer, SR; Iwakuma, N; Jiang, H; Knapik, J; Koopman, B; Krishna, V; Moudgil, B; Sharma, P; Singh, A; Wang, Q; Zhang, Q | 1 |
| Gao, X; Jia, L; Liang, X; Lu, J; Meng, J; Wang, PC; Wang, Y; Xing, J; Zhao, Y | 1 |
| Grobmyer, SR; Krishna, V | 1 |
1 review(s) available for fullerene c60 and Breast Cancer
| Article | Year |
|---|---|
Caging cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Drug Delivery Systems; Female; Fullerenes; Gadolinium; Humans | 2015 |
17 other study(ies) available for fullerene c60 and Breast Cancer
| Article | Year |
|---|---|
Glycinated fullerenes for tamoxifen intracellular delivery with improved anticancer activity and pharmacokinetics.
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Fullerenes; Glycine; Humans; MCF-7 Cells; Nanoconjugates; Rats, Wistar; Tamoxifen | 2017 |
Synthesis and evaluation of anticancer activity in cells of novel stoichiometric pegylated fullerene-doxorubicin conjugates.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Cell Proliferation; Doxorubicin; Drug Delivery Systems; Drug Liberation; Female; Fullerenes; Humans; MCF-7 Cells; Polyethylene Glycols | 2015 |
A tumor-specific cleavable nanosystem of PEG-modified C60@Au hybrid aggregates for radio frequency-controlled release, hyperthermia, photodynamic therapy and X-ray imaging.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Contrast Media; Delayed-Action Preparations; Doxorubicin; Female; Fullerenes; Gold; Humans; Hyperthermia, Induced; Mice; Mice, Inbred BALB C; Polyethylene Glycols; Radiography; Xenograft Model Antitumor Assays | 2016 |
Combined cancer therapy with hyaluronan-decorated fullerene-silica multifunctional nanoparticles to target cancer stem-like cells.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Liberation; Female; Fullerenes; Humans; Hyaluronic Acid; Hyperthermia, Induced; Infrared Rays; Mice, Nude; Nanoparticles; Neoplastic Stem Cells; Photochemotherapy; Phototherapy; Silicon Dioxide | 2016 |
Lipid Heterogeneity Resulting from Fatty Acid Processing in the Human Breast Cancer Microenvironment Identified by GCIB-ToF-SIMS Imaging.
Topics: Argon; Breast Neoplasms; Fatty Acids; Female; Fullerenes; Humans; Ions; Lipids; Optical Imaging; Spectrometry, Mass, Secondary Ion; Tumor Microenvironment | 2016 |
Modulating activity of fullerol C60(OH)22 on doxorubicin-induced cytotoxicity.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Combinations; Drug Screening Assays, Antitumor; Electron Spin Resonance Spectroscopy; Female; Fullerenes; Humans; Hydrogen Peroxide; Hydroxyl Radical; Iron; Spin Trapping | 2004 |
Topics: Breast Neoplasms; Female; Fullerenes; Humans; MCF-7 Cells; Nanostructures; Triazoles | 2022 |
Fullerenol inhibits the cross-talk between bone marrow-derived mesenchymal stem cells and tumor cells by regulating MAPK signaling.
Topics: Animals; Bone Marrow; Breast Neoplasms; Cell Movement; Female; Fullerenes; Humans; MAP Kinase Signaling System; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Nanoparticles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2017 |
Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer.
Topics: Animals; Biomarkers, Tumor; Breast Neoplasms; Female; Fullerenes; Gadolinium; Humans; Magnetic Resonance Imaging; MCF-7 Cells; Mice; Precision Medicine; Triple Negative Breast Neoplasms | 2017 |
Fullerene as a doxorubicin nanotransporter for targeted breast cancer therapy: Capillary electrophoresis analysis.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Doxorubicin; Drug Carriers; Drug Liberation; Electrophoresis, Capillary; Fluorescent Dyes; Fullerenes; Humans; Hydrogen-Ion Concentration; MCF-7 Cells; Nanoparticles; Optical Imaging; Particle Size; Surface Properties | 2018 |
Small size fullerenol nanoparticles suppress lung metastasis of breast cancer cell by disrupting actin dynamics.
Topics: Actin Cytoskeleton; Actins; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Elastic Modulus; Female; Fullerenes; Humans; Integrins; Lung Neoplasms; Mice, Nude; Nanoparticles | 2018 |
Photodynamic therapy of a 2-methoxyestradiol tumor-targeting drug delivery system mediated by Asn-Gly-Arg in breast cancer.
Topics: 2-Methoxyestradiol; Animals; Apoptosis; Breast Neoplasms; Cell Proliferation; Cell Survival; DNA Fragmentation; Drug Carriers; Estradiol; Female; Fullerenes; Humans; Malonates; MCF-7 Cells; Mice; Oligopeptides; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species | 2013 |
Buckysomes: fullerene-based nanocarriers for hydrophobic molecule delivery.
Topics: Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Fullerenes; Humans; Hydrophobic and Hydrophilic Interactions; Nanostructures; Paclitaxel | 2008 |
Fullerene-conjugated doxorubicin in cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Compounding; Fullerenes; Humans | 2010 |
Polyhydroxy fullerenes for non-invasive cancer imaging and therapy.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Fullerenes; Humans; Mice; Mice, Nude; Microscopy, Atomic Force; Nanoparticles; Phototherapy | 2010 |
Epigenetic modulation of human breast cancer by metallofullerenol nanoparticles: in vivo treatment and in vitro analysis.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Survival; Crystallization; Epigenesis, Genetic; Fullerenes; Gadolinium; Humans; Nanocapsules; Nanomedicine; Nanostructures; Particle Size; Treatment Outcome | 2011 |
Minimally invasive cancer therapy using polyhydroxy fullerenes.
Topics: Animals; Breast Neoplasms; Contrast Media; Female; Fullerenes; Magnetic Resonance Imaging, Interventional; Mammography; Mice; Photosensitizing Agents; Phototherapy | 2012 |